Kurzfassung

A prospective, double-masked, randomized, multicenter, activecontrolled, parallel-group, 6-month study assessing the safety and
ocular hypotensive efficacy of PG324 Ophthalmic Solution
compared to GANFORT (bimatoprost 0.03%/timolol 0.5%)
Ophthalmic Solution in subjects with elevated intraocular pressure